Human Resources Manager

Immix Biopharma (Nasdaq: IMMX); Los Angeles (CA); On-site; USD 95,000 - 135,000; Full time

Job summary

Immix Biopharma is seeking an experienced HR Manager to lead people operations in a fast-paced biopharma environment.

You will design HR strategies, manage recruitment, administer compensation programs, and ensure compliance across the organization. A strong emphasis on employee relations, policy development, and training will guide ongoing people initiatives.

Qualifications

• 2+ years of HR management experience or similar role.
• Strong knowledge of employment laws and HR best practices.
• Experience in recruitment, employee relations and performance management.

Responsibilities

• Develop and implement HR strategies aligned with organizational goals.
• Manage recruitment, postings, interviews, and onboarding.
• Oversee compensation and benefits programs to ensure competitiveness.
• Provide guidance on employee relations, performance reviews, and discipline.
• Ensure compliance with laws and company policies.
• Develop/update HR policies and procedures.
• Coordinate training and development initiatives.
• Foster positive work environment and retention.
• Maintain HR records with data accuracy and confidentiality.
• Lead HR team with direction and professional development.

Skills

HR management

Leadership

Recruitment

Employee relations

Performance management

Policy development

HR software

Microsoft Office

Education

PHR/SPHR cert

SHRM-CP/SCP

Tools

Workday

SAP SuccessFactors

ADP Workforce Now

Job description

Our mission is to harness the immune system through innovative cell therapies and other modalities to deliver widely accessible cures. Patients are waiting!

What You'll Do:

• Develop and implement HR strategies and initiatives that align with the organization's goals.
• Manage the recruitment and selection process, including job postings, interviews, and onboarding.
• Administer compensation and benefits programs, ensuring competitive and fair packages for employees.
• Provide support and guidance to managers and employees on HR-related issues, including employee relations, performance management, and disciplinary actions.
• Ensure compliance with employment laws, regulations, and company policies.
• Develop and update HR policies and procedures as needed.
• Coordinate employee training and development programs to enhance skills and performance.
• Foster a positive work environment and promote employee engagement and retention.
• Manage HR records and ensure data accuracy and confidentiality.
• Lead the HR team, providing direction, support, and professional development.

Skills and Experience we look for:

• Proven experience as a Human Resources Manager or similar HR role.
• Comprehensive knowledge of employment laws, regulations, and HR best practices.
• Excellent leadership and interpersonal skills.
• Strong communication and problem-solving abilities.
• Experience in recruitment, employee relations, and performance management.
• Ability to work collaboratively with all levels of the organization.
• Strong organizational and time management skills.
• Proficiency in HR software and Microsoft Office Suite.

Education:

• Professional certification such as PHR, SPHR, SHRM-CP, or SHRM-SCP is highly desirable.
• At least 2 years of experience in HR management or a related role is desired
• Experience in employee training and development is a plus

About Immix Biopharma, Inc.

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a global leader in relapsed/refractory AL Amyloidosis. AL Amyloidosis is a devastating disease where the immune system, that’s supposed to protect, instead produces toxic light chains, clogging up the heart, kidney and liver, causing organ failure and death. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a “digital filter” that is designed to filter out non‑specific activation. NXC-201 teaches the immune system to recognize and eliminate the source of the toxic light chains. NXC-201 is being evaluated in the U.S. multi‑center study for relapsed/refractory AL Amyloidosis NEXICART‑2 (NCT06097832), with a registrational design. NXC-201 has been awarded Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA. Learn more at www.immixbio.com and www.BeProactiveInAL.com.